A Single-Center Study Evaluating the Effects of a Novel Retinol and Cannabidiol Combination Topical on Facial Skin

Julius Few, Michael J Lee, Alec Semersky, Emily Mariscal, Ginny Vachon, Julius Few, Michael J Lee, Alec Semersky, Emily Mariscal, Ginny Vachon

Abstract

Background: While retinol is known to reduce the appearance of fine lines and wrinkles, it is associated with irritating effects. However, when combined with water soluble cannabidiol (CBD; CR Topical), CBD may act to reduce oxidative stress and inflammation, mitigating irritation from retinol and further improving the skin's appearance through independent anti-aging mechanisms.

Objectives: To assess the efficacy and tolerability of CR-Topical for improving facial skin.

Methods: In this prospective, single-center pilot study, 9 female patients and one male patient aged 20 to 53 years who presented with facial skin imperfections (visible pores, dehydration, roughness, and/or static/dynamic wrinkles) applied CR-Topical to the entire face once daily for 42 days. Outcomes were measured on days 1, 21, and 42 using the Global Ranking Scale (GRS) with Comprehensive Skin Analysis by the patient and senior investigator as well as by a blinded reviewer (board-certified plastic surgeon). Dynamic videos and static imagery were taken before and after treatment, and patient satisfaction surveys were completed.

Results: Global improvement across all 13 domains was observed, with the greatest mean differences for visible pores (2.0; 95% CI, 1.5-2.5), dehydration (2.0; 95% CI, 1.4-2.6), surface roughness (1.8; 95% CI, 1.2-2.4), static wrinkles (1.8; 95% CI, 1.1-2.5), and dynamic wrinkles (1.6; 95% CI, 0.8-2.3). Patient satisfaction (100%) and willingness to recommend the product to others (90%) were high, and tolerability of CR-Topical was excellent.

Conclusions: CR-Topical is effective at improving global skin quality, including static and dynamic wrinkles. This study also used 4-dimensional analysis in the evaluation, a novel and developing method.

© 2022 The Aesthetic Society.

Figures

Figure 1.
Figure 1.
Global Ranking Scale and Comprehensive Skin Analysis. Scale adapted from Jain et al..
Figure 2.
Figure 2.
Facial skin appearance across domains at baseline (blue) and Day 42 (teal).
Figure 3.
Figure 3.
Mean change among domains from baseline for the Global Ranking Scale (teal circles) and Skin Quality domains (blue circles) with 95% CIs (navy blue bars).
Figure 4.
Figure 4.
Patient satisfaction and functional outcomes measured using the patient survey.
Figure 5.
Figure 5.
A 20-year-old male (A-E) at baseline with facial skin characterized by active acne blemishes, acne scarring, and hyperpigmentation; and (F-J) after 42 days of nightly application of CR-Topical. Note the significant decrease in the intensity of acne-related hyperpigmentation and the appearance of inflammation. Additionally, the facial skin is more hydrated, indicated by the more even distribution of light.
Figure 6.
Figure 6.
A 53-year-old female (A-E) at baseline with facial skin characterized by excessive global fine lines and lentigines; and (F-J) after 42 days of nightly application of CR-Topical. Note the shallow depths of the fine wrinkles in the running vertically on the cheek and horizontally in the crow’s feet region. Additionally, the highly pigmented lentigines brought on by excessive sun or age have lightened significantly.
Figure 7.
Figure 7.
Representative close up images of the 20-year-old male shown in Figure 5 (A) at baseline and (B) after 42 days of nightly applications of CR Topical; and the 53-year-old female shown in Figure 6 (C) at baseline and (D) after 42 days of nightly application of CR Topical.

References

    1. Zhang S, Duan E. Fighting against skin aging: the way from bench to bedside. Cell Transplant. 2018;27(5):729-738. doi:10.1177/0963689717725755
    1. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92(20):9363-9367. doi:10.1073/pnas.92.20.9363
    1. Kohl E, Steinbauer J, Landthaler M, Szeimies RM. Skin ageing. J Eur Acad Dermatol Venereol. 2011;25(8): 873-884. doi:10.1111/j.1468-3083.2010.03963.x
    1. Friedman O. Changes associated with the aging face. Facial Plast Surg Clin North Am. 2005;13(3):371-380. doi:10.1016/j.fsc.2005.04.004
    1. Rinnerthaler M, Bischof J, Streubel MK, et al. Oxidative stress in aging human skin. Biomolecules 2015;5(2): 545-589. doi:10.3390/biom5020545
    1. Tsuchida K, Kobayashi M. Oxidative stress in human facial skin observed by ultraweak photon emission imaging and its correlation with biophysical properties of skin. Sci Rep. 2020;10(1):9626. doi:10.1038/s41598-020-66723-1
    1. Mukherjee S, Date A, Patravale V, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327-348. doi:10.2147/ciia.2006.1.4.327
    1. Zasada M, Budzisz E. Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments. Postepy Dermatol Alergol. 2019;36(4): 392-397. doi:10.5114/ada.2019.87443
    1. Hubbard BA, Unger JG, Rohrich RJ. Reversal of skin aging with topical retinoids. Plast Reconstr Surg. 2014;133(4):481e-490e. doi:10.1097/PRS.0000000000000043
    1. Wang H, Liu K, Geng M, et al. RXRα inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2. Cancer Res. 2013;73(10):3097-3108. doi:10.1158/0008-5472.CAN-12-3386
    1. Klassen AF, Cano SJ, Schwitzer JA, Scott AM, Pusic AL. FACE-Q scales for health-related quality of life, early life impact, satisfaction with outcomes, and decision to have treatment: development and validation. Plast Reconstr Surg. 2015;135(2):375-386. doi:10.1097/PRS.0000000000000895
    1. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29(6):588-595. doi:10.1046/j.1524-4725.2003.29150.x
    1. Jain R, Huang P, Ferraz RM. A new tool to improve delivery of patient-engaged care and satisfaction in facial treatments: the Aesthetic Global Ranking Scale. J Cosmet Dermatol. 2017;16(1):132-143. doi:10.1111/jocd.12297
    1. Cartier H, Hedén P, Delmar H, et al. Repeated full-face aesthetic combination treatment with abobotulinumtoxinA, hyaluronic acid filler, and skin-boosting hyaluronic acid after monotherapy with abobotulinumtoxinA or hyaluronic acid filler. Dermatol Surg. 2020;46(4):475-482. doi:10.1097/DSS.0000000000002165
    1. Kim BH, Lee YS, Kang KS. The mechanism of retinol-induced irritation and its application to anti-irritant development. Toxicol Lett. 2003;146(1):65-73. doi:10.1016/j.toxlet.2003.09.001
    1. Sholler DJ, Schoene L, Spindle TR. Therapeutic efficacy of cannabidiol (CBD): a review of the evidence from clinical trials and human laboratory studies. Curr Addict Rep 2020;7(3):405-412. doi:10.1007/s40429-020-00326-8
    1. Palmieri B, Laurino C, Vadalà M. A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars. Clin Ter 2019;170(2):e93-e99. doi:10.7417/CT.2019.2116
    1. Oláh A, Tóth BI, Borbíró I, et al. Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. J Clin Invest. 2014;124(9):3713-3724. doi:10.1172/JCI64628
    1. Casares L, García V, Garrido-Rodríguez M, et al. Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020;28:101321. doi:10.1016/j.redox.2019.101321
    1. Baswan SM, Klosner AE, Glynn K, et al. Therapeutic potential of cannabidiol (CBD) for skin health and disorders. Clin Cosmet Investig Dermatol. 2020;13:927-942. doi:10.2147/CCID.S286411
    1. Few JW, Pintas S, Smith JR, Vachon G. Nonsurgical tissue repositioning: analysis of long-term results and patient satisfaction from 100 absorbable suture suspension cases. Aesthet Surg J Open Forum. 2019;2(1):1-13. doi:10.1093/asjof/ojz029

Source: PubMed

3
구독하다